We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Novacyt S.a. | NCYT | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
50.00 | 50.00 | 50.40 | 50.80 |
Industry Sector |
---|
HEALTH CARE EQUIPMENT & SERVICES |
Top Posts |
---|
Posted at 04/2/2025 08:27 by george192 Doesnt matter to NCYT about MPOX no monies or contracts from it ever no Govt contracts ever again and no contracts for past 5 years |
Posted at 21/1/2025 15:50 by george192 Another court case against NCYT never ever getting any Govt contracts again |
Posted at 26/12/2024 13:08 by robertbarns1 we are heading back to 10p or lowerNCYT will have no future in UK after the court case decision |
Posted at 24/12/2024 17:37 by robertbarns1 the only winners are the shortersfrom 1200p / 1000p to todays level dazzaman no CONTRACTS .. NCYT are toast |
Posted at 20/12/2024 16:34 by george192 NCYT will never never be allowed a UK Govt contract again and if you think they will you are delluded |
Posted at 04/12/2024 21:33 by george192 NCYT will never get a UK contract again end of there reputation has been tarnished no contracts ever again from anyone no contracts in 5 yrs so why now ??? |
Posted at 12/9/2024 15:43 by dudishes Just 3 shorts on the books at the moment, PAGE, BRBY and NCYT.NCYT by far the winner, 30%+ and counting. Have I got it wrong? Unaudited accounts to be re issued? Maybe an attempt for saving face, but not saving money as it costs. BTW, Yourgene, cost NCYT over £16M. |
Posted at 10/9/2024 13:55 by aimgamblerssupportgroup Are you slow on the uptake Baldrick?Please tell me where you expect the profit to come from, I am all ears. Yougene last full year results before NCYT Turnover £37.6 million loss £3.4 million (includes covid 19 sales) -------------------- NCYT 2024 30th May Turnover £11.5 million] Loss £28 million w/ex £17.8 million -------------------- As from the last NCYT results, on a pro-rata rate assuming the acquisition of Yougene was a full trading year 2023 reulsts are thus. Revenue £22.8 million full-year loss of 50 million. So the group went form a proforma £47 mill revenue to £22.8 in 2023. and a loss of £31 million to £50 million. Horrid! |
Posted at 16/8/2024 12:59 by blakesmith Uk No cases No need for testVaccine already in place Ncyt owes £5m to DHSCNCYT LOSING CASH MONTHLYNCYT NEEDS TO PLACE VOLUME ALONE IS A GIVE away that placing shares is being forward sold Ncyt making loss now Pre Covid 6p Needs to return to theee levels |
Posted at 14/6/2024 20:10 by wad collector Blackhorse , you have forgotten that you already claimed several occasions to have sold out here and bought APH but never claim to have bought any here. Not that I am questioning your honesty of course...Blackhorse23 - 14 Jun 2024 - 08:37:45 - 68536 of 68540 COVID-19 - NCYT Out from here & bought APH Blackhorse23 - 30 May 2024 - 10:42:09 - 68476 of 68540 COVID-19 - NCYT Money moving to APH ( alliance pharma ) Blackhorse23 - 18 Apr 2024 - 10:22:48 - 68397 of 68540 COVID-19 - NCYT AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders -DIVIDEND +5% -PORTFOLIO BROADENED THROUGH ACQUISITION Blackhorse23 - 21 Feb 2024 - 15:29:50 - 68371 of 68540 COVID-19 - NCYT Money moving to APH , excellent growth health care company Blackhorse23 - 29 Jan 2024 - 15:32:53 - 68369 of 68540 COVID-19 - NCYT Blackhorse23 - 16 Jan 2024 - 15:39:29 - 68362 of 68540 COVID-19 - NCYT Out from here & reinvested in APH Blackhorse23 - 28 Nov 2023 - 09:47:03 - 68342 of 68540 COVID-19 - NCYT Money moving to APH Blackhorse23 - 23 Nov 2023 - 10:12:40 - 68331 of 68540 COVID-19 - NCYT Switched to APH Blackhorse23 - 09 Nov 2023 - 11:35:09 - 68326 of 68540 COVID-19 - NCYT Blackhorse23 - 07 Nov 2023 - 09:10:12 - 68315 of 68540 COVID-19 - NCYT Money moving to APH , out from profit & going to buy A |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions